1Elevan Bio

1Elevan Bio

Approved
Cambridge, United StatesFounded 20211elevan.com

1Elevan Bio is redefining the future of medicine through leading-edge scientific research and advanced medication delivery systems. Specializing in FDA-approved and FDA-expanded-access peptides, we are committed to providing therapies that offer enhanced efficacy, superior safety profiles, and fewer unwanted side effects than traditional pharmaceutical approaches. Our focus on precision peptide therapeutics is driving a transformative shift in how diseases are treated—safely and effectively.

Founded
2021
Focus
Cell TherapyImmunology

About

1Elevan Bio is redefining the future of medicine through leading-edge scientific research and advanced medication delivery systems. Specializing in FDA-approved and FDA-expanded-access peptides, we are committed to providing therapies that offer enhanced efficacy, superior safety profiles, and fewer unwanted side effects than traditional pharmaceutical approaches. Our focus on precision peptide therapeutics is driving a transformative shift in how diseases are treated—safely and effectively.

Company Info

TypePrivate
Founded2021
LocationCambridge, United States
StageApproved
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile